Jeffrey Zerillo Biography and Net Worth

Jeff Zerillo was appointed to Prestige Brands as Senior Vice President, Operations in April, 2018 to lead the Company’s diversified supply chain. Jeff joined the Company from Teva Pharmaceuticals where he served as Vice President, Supply Chain Management for the America’s Region. He brings over 30 years of extensive prior experience managing complex Supply Chain’s in Pharmaceuticals, Biologics and Medical Device from companies including Actavis/Allergan, Purdue Pharma and Instrumentation Laboratories. He earned a B.S. in Production Operations Management from York College of Pennsylvania and an Executive Certificate from Sloan School of Business.

What is Jeffrey Zerillo's net worth?: The estimated net worth of Jeffrey Zerillo is at least $2.71 million as of November 28th, 2025. Zerillo owns 42,329 shares of Prestige Consumer Healthcare stock worth more than $2,710,326 as of January 28th. This net worth estimate does not reflect any other assets that Zerillo may own. Additionally, Zerillo receives an annual salary of $496,910.00 as VP at Prestige Consumer Healthcare. Learn More about Jeffrey Zerillo's net worth.
How old is Jeffrey Zerillo?: Zerillo is currently 63 years old. There are 3 older executives and no younger executives at Prestige Consumer Healthcare. Learn More on Jeffrey Zerillo's age.
What is Jeffrey Zerillo's salary?: As the VP of Prestige Consumer Healthcare Inc., Zerillo earns $496,910.00 per year. There are 4 executives that earn more than Zerillo. The highest earning executive at Prestige Consumer Healthcare is Mr. Ronald M. Lombardi, Chairman, President & CEO, who commands a salary of $1,980,000.00 per year. Learn More on Jeffrey Zerillo's salary.
How do I contact Jeffrey Zerillo?: The corporate mailing address for Zerillo and other Prestige Consumer Healthcare executives is 660 WHITE PLAINS ROAD SUITE 250, TARRYTOWN NY, 10591. Prestige Consumer Healthcare can also be reached via phone at (914) 524-6800 and via email at [email protected]. Learn More on Jeffrey Zerillo's contact information.
Has Jeffrey Zerillo been buying or selling shares of Prestige Consumer Healthcare?: Jeffrey Zerillo has not been actively trading shares of Prestige Consumer Healthcare over the course of the past ninety days. Most recently, Jeffrey Zerillo sold 281 shares of the business's stock in a transaction on Monday, December 1st. The shares were sold at an average price of $60.00, for a transaction totalling $16,860.00. Following the completion of the sale, the vice president now directly owns 42,048 shares of the company's stock, valued at $2,522,880. Learn More on Jeffrey Zerillo's trading history.
Who are Prestige Consumer Healthcare's active insiders?: Prestige Consumer Healthcare's insider roster includes Mary Beth Fritz (SVP), Ronald Lombardi (Insider), Adel Mekhail (EVP, Marketing & Sales), William P'pool (SVP, General Counsel and Corporate Secretary), and Jeffrey Zerillo (VP). Learn More on Prestige Consumer Healthcare's active insiders.
Are insiders buying or selling shares of Prestige Consumer Healthcare?: In the last year, insiders at the sold shares 3 times. They sold a total of 2,678 shares worth more than $211,020.00. The most recent insider tranaction occured on December, 1st when VP Jeffrey Zerillo sold 281 shares worth more than $16,860.00. Insiders at Prestige Consumer Healthcare own 1.4% of the company. Learn More about insider trades at Prestige Consumer Healthcare.
Information on this page was last updated on 12/1/2025.

Jeffrey Zerillo Insider Trading History at Prestige Consumer Healthcare

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction	Details
12/1/2025	Sell	281	$60.00	$16,860.00	42,048
11/28/2025	Sell	719	$60.00	$43,140.00	42,329

Jeffrey Zerillo Buying and Selling Activity at Prestige Consumer Healthcare

Prestige Consumer Healthcare Company Overview

Prestige Consumer Healthcare Inc., together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) health and personal care products in the United States and internationally. The company operates in two segments, North American OTC Healthcare and International OTC Healthcare. It offers BC/Goody's analgesic powders, Boudreaux's Butt Paste baby ointments, Chloraseptic sore throat liquids and lozenges, Clear Eyes for eye redness relief, Compound W wart removals, DenTek for PEG oral care, Debrox ear wax removals, and Dramamine for motion sickness relief. The company also provides Fleet adult enemas/suppositories, Gaviscon upset stomach remedies, Luden's cough drops, Monistat vaginal anti-fungal, Nix lice/parasite treatments, Summer's Eve feminine hygiene, TheraTears dry eye relief, Fess nasal saline spray and washes, and Hydralyte for oral rehydration products. It sells its products through mass merchandisers; and drug, food, dollar, convenience, and club stores, as well as e-commerce channels. The company was formerly known as Prestige Brands Holdings, Inc. and changed its name to Prestige Consumer Healthcare Inc. in August 2018. Prestige Consumer Healthcare Inc. was founded in 1996 and is headquartered in Tarrytown, New York.

Today's Range

Now: $63.53

$63.23

$64.12

50 Day Range

MA: $62.23

$57.45

$67.76

2 Week Range

Now: $63.53

$57.25

$90.04

Volume

168,493 shs

Average Volume

340,931 shs

Market Capitalization

$3.05 billion

P/E Ratio

15.74

Dividend Yield

N/A

Beta

0.4

Jeffrey Zerillo Biography and Net Worth

What is Jeffrey Zerillo's net worth?

How old is Jeffrey Zerillo?

What is Jeffrey Zerillo's salary?

How do I contact Jeffrey Zerillo?

Has Jeffrey Zerillo been buying or selling shares of Prestige Consumer Healthcare?

Who are Prestige Consumer Healthcare's active insiders?

Are insiders buying or selling shares of Prestige Consumer Healthcare?